Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,812 | 14,687 | 16,895 | 17,801 | 27,704 |
| Receivables | 1,082 | 866 | 1,662 | 1,609 | 1,115 |
| Other current assets | 108 | 265 | 113 | 116 | 110 |
| TOTAL | $34,503 | $17,928 | $20,466 | $20,883 | $29,422 |
| Non-Current Assets | |||||
| PPE Net | 420 | 330 | 330 | 322 | 308 |
| TOTAL | $420 | $330 | $330 | $322 | $308 |
| Total Assets | $34,923 | $18,258 | $20,796 | $21,205 | $29,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,416 | 1,400 | 1,390 | 1,375 | 1,363 |
| Accounts payable and accrued liabilities | 4,235 | 4,282 | 4,602 | 4,605 | 4,347 |
| Accrued Expenses | 2,191 | 2,667 | 2,712 | 2,977 | 5,275 |
| TOTAL | $28,003 | $8,430 | $8,785 | $9,038 | $11,061 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $28,003 | $8,430 | $8,785 | $9,038 | $11,061 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,911 | 15,819 | 15,812 | 14,620 | 15,080 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -132,947 | -130,197 | -126,824 | -124,018 | -121,698 |
| Other shareholders' equity | -1,531 | -1,211 | -2,009 | -2,026 | -630 |
| TOTAL | $6,920 | $9,828 | $12,011 | $12,167 | $18,669 |
| Total Liabilities And Equity | $34,923 | $18,258 | $20,796 | $21,205 | $29,730 |